Ibrahim El-Battrawy, Katharina Koepsel, David Tenbrink, Boldizsar Kovacs, Tobias C Dreher, Christian Blockhaus, Michael Gotzmann, Norbert Klein, Thomas Kuntz, Dong-In Shin, Hendrik Lapp, Stephanie Rosenkaimer, Mohammad Abumayyaleh, Nazha Hamdani, Ardan Muammer Saguner, Jacqueline Kowitz, Julia W Erath, Firat Duru, Andreas Mügge, Ibrahim Akin, Assem Aweimer, Thomas Beiert
Background Data on the use of the wearable cardioverter-defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. Methods and Results In total, 1596 consecutive patients were included in a multicenter registry from 8 European centers, with 124 patients (8%) having received the WCD due to myocarditis and reduced left ventricular ejection fraction or prior ventricular tachyarrhythmia. The mean age was 51.6±16...
September 8, 2023: Journal of the American Heart Association